Dr. Kyle G. Cologne, MD

Dr. Cologne practices at USC Care Medical Group, Inc in Glendale, California.

Dr. Cologne's NPI, 1164678082, was assigned on August 12, 2008. Dr. Cologne graduated from Keck School of Medicine of USC in 2006. Dr. Cologne holds California license A115483.

Dr. Cologne's primary practice is USC Care Medical Group, Inc, at 1808 Verdugo Blvd, Glendale, CA 91208 in Los Angeles County. The practice phone is (323) 442-5955.

Dr. Cologne's primary practice is USC Care Medical Group, Inc in Glendale, California. Dr. Cologne is also affiliated with USC Verdugo Hills Hospital. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Cologne to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cologne practices, 4 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Cologne's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Cologne is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Cologne's licenses on file in 2 states: California and Illinois.

Dmand AI lists colonoscopy, colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Cologne treats.

CMS data shows 292 Medicare services from Dr. Cologne across 12 procedure codes in 2024, for 241 Medicare patients. Medicare paid $24,167 for them.

CMS counts 241 Medicare patients who saw Dr. Cologne in 2024. The largest group is 65 to 74, with 107 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cologne's median patient age at 58, with 41% women.

In 2024, Dr. Cologne wrote 24 Medicare Part D claims for 21 patients. 79% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $34 in total drug cost. In 2021, CMS named 14 claims across 1 drug.

Dr. Cologne accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cologne as offering telehealth. CMS counts 80 procedures of colonoscopy by Dr. Cologne, more than 74% of the clinicians it reports for that procedure.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Cologne, published from 2014 to 2024. 2016 was the busiest year, with 2. Dr. Cologne has published most often in Dis Colon Rectum. Dr. Cologne's most frequent co-authors are Deborah Keller, MD, Jordan Wlodarczyk, MD, MS and Seyed Arshia Arshad, MD.

Dmand AI links Dr. Cologne to 1 clinical trial. Conditions studied include Surgical Wound Infection and Wound Infection.

CMS Open Payments shows 80 general payments to Dr. Cologne from 25 drug and device companies from 2016 to 2025. Education make up the largest share, 87% of the total. Olympus Corporation of the Americas paid the most, $34,351.

Dmand AI lists 4 awards for Dr. Cologne, most recently Pasadena Top Doctor in 2014.

Dr. Cologne graduated from Keck School of Medicine of USC in 2006. Dr. Cologne is a member of ACS, ASCRS and SAGES.

Dr. Cologne is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.